Interstitial Lung Disease Trial, Recruiting NCT06159660 Sponsor: University of Sydney Condition: Interstitial Lung Disease
Back to Interstitial Lung Disease

Interstitial Lung Disease Trial, Recruiting

NCT06159660
Recruiting Not Applicable 🇦🇺 Australian site

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People with a general health and activity level rated between 0 and 2 on a standard oncology scale (meaning able to carry out at least some daily activities — confirm with trial site)
  • People who have been diagnosed with Stage II, III, or IV non-small cell lung cancer, confirmed through laboratory analysis of tissue
  • People whose treatment plan involves external beam radiation therapy (but not a specific high-precision type called SABR), given either with the goal of curing the cancer (Stages II–III) or managing it (Stage IV)
  • People who have had breathing/lung function tests done within 8 weeks of registering for the trial
  • People whose radiation treatment planning includes a specific type of scan that tracks breathing movement (called a 4DCT simulation)
  • People who are willing to sign a written consent form
  • People who are willing and able to follow the study's procedures and attend all required visits
  • People who are able to be followed up for 1 year after joining, or until death, whichever comes first

Who may not be able to join:

  • People who have previously had radiation therapy to the chest area
  • People who have already had surgery to treat this lung cancer
  • People who have already received chemotherapy for this lung cancer
  • People who have a condition called interstitial lung disease (a group of conditions that cause scarring in the lungs)
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ricky O'Brien, University of Sydney

Phone: +61 2 8627 1185

Australian sites

Royal North Shore Hospital, St Leonards, New South Wales
+61 2 9463 1339

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Sydney
Registry
ClinicalTrials.gov
Start date
17 February 2025
Est. completion
1 September 2026

Where this trial is recruiting

🇦🇺 Australia

1 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Physiological accuracy of X-ray-based ventilation imaging (BHCT, fluoroscopy, 4DCBCT, 4DCT)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov